Leading portfolio innovation strategy for Abbott's Freestyle Libre division, partnering with our Global AI Center of Excellence and commercial leadership to translate breakthrough capabilities into products that serve millions of diabetes patients worldwide.

My role sits at the intersection of cutting-edge technology and real-world commercial application, translate complex models into real-world solutions across North America, EMEA, APAC, and LATAM. Defining how we leverage global toolchains, LLMs, advanced analytics, and machine learning to transform our commercial, digital, and customer experience operations.

What I'm working on:

• Building an AI product roadmap for commercial excellence; what does intelligent sales, predictive analytics, and hyper-personalized experiences look like in Abbott Diabetes Care...

• Partnering with C-suite executives and business directors to identify high-impact AI opportunities, define success metrics, and translate AI capabilities into measurable business outcomes

• Leading a team responsible for strategic portfolio planning and delivery for our commercial, digital, and customer experience teams.

• Establishing responsible AI frameworks for healthcare applications, ensuring we innovate rapidly while maintaining patient data privacy (GDPR, HIPAA), algorithmic fairness, and regulatory compliance across global markets.

The unique challenge: balancing speed and innovation with the safety, compliance, and clinical rigor required in healthcare. We're applying learnings to a highly regulated industry serving vulnerable patients.

Technologies: Generative AI (GPT-4, Claude, proprietary LLMs), Advanced Analytics & ML Platforms, Commercial A Applications, Healthcare Data Systems, Responsible AI Frameworks

This role builds on my experience as Chief Product Officer of Abbott Lingo, where I created an entirely new category of AI-powered biowearables from zero to FDA clearance and market launch.

Built Abbott's Lingo consumer biowearables division from zero to FDA clearance and market launch; creating an entirely new category of AI-powered biosensors that help people understand and improve their health.

I built and led a cross-functional team of 40 (Product, Data Science, UX, CRM, Hardware, Program Management, Insights) to design, develop, and ship a product that combines continuous glucose monitoring with AI-powered personalization.

What we built:

• AI/ML personalization engine processing millions of glucose readings daily to deliver hyper-personalized health insights and real-time coaching

• Consumer experience achieving >8 app opens/day, 5.5/7 CSAT, and 2x expected LTV

• Product-market fit validated by user outcomes: 9/10 report habit change, 7/10 achieve a health goal

• Growth engine combining direct-to-consumer channels and strategic retail partnerships (Amazon, major pharmacy chains)

The breakthrough: Secured one of the first-ever FDA OTC designations for continuous glucose monitors; unlocking mass-market opportunity and positioning Lingo to win this brand new category.

This role combined the speed and customer-obsession of consumer tech (my Amazon background) with the clinical rigor and regulatory compliance of healthcare, exactly the balance needed for responsible AI product development.

Technologies: ML/AI Personalization, Biosensor Technology, Mobile Health Platforms, Clinical Data Science, FDA Regulatory Strategy

Rejoined Amazon to evolve the apps and games engine responsible for driving a large portion of Amazon Devices annual growth—owning the commercial delivery and development submission for every device on Amazon (e.g., FireTV, Fire Tablets, and Android). Tapped in May 2021 to take on a first-of-its kind senior leadership role introducing a new Amazon healthcare initiative worldwide.

Global Head of Product, Marketing, Regulatory, & UX | New Emerging Products (5/21–present)

Global Head of Product & UX | Appstore & Coins (4/20–5/21)

Founded a revenue growth consultancy to help traditional companies create digital strategies that harness organization’s existing capabilities. Built product and organization strategies for ten early-stage / self-funded start-up clients, including iHerb and SunPantry. Services included acting as an interim VP of Product for a $1.5B+ annual P&L, in addition to strategic roadmapping, branding, and digital transformations; operational and technology overhauls; acquisition positioning; and global logistics.